Global Tumor Ablation Market - Growth, Trends, and Forecasts 2017 - 2022

  • ID: 4388591
  • Report
  • Region: Global
  • 211 pages
  • Mordor Intelligence
1 of 3
The global tumor ablation market accounted for USD 350 million in 2015 and is estimated to reach USD 406 million in 2016. The market is expected to reach USD 765 million by 2021 and is projected to grow at a CAGR of 13.5 % from 2016 to 2021.

Market Dynamics

The tumor ablation market is growing at a considerable rate owing to factors such as the increasing incidence of cancer, increasing awareness of ablation procedures, which are better than surgeries for tumors no longer than 3 cm, and increasing demand for minimally invasive cancer procedures. In addition, the rising geriatric population, increase in the number of hospitals, ablation and surgical centers, technological advancement in ablation devices, increase in awareness for personalized drugs, and increase in healthcare expenditure are other factors driving the market growth. However, the strict regulatory process is a restraint to the growth.

The key opportunities for the global tumor ablation market are increasing investment in R&D of novel therapies and considerable support from governments to develop the therapies. The massive untapped markets in the emerging countries are creating a lot of opportunities for the global tumor ablation market. However, the long approval time for product launches is the key challenge faced by the market.

Global Tumor Ablation Market segmentation

The global tumor ablation market is segmented by the type of technology into-

Radiofrequency (rf) ablation

Microwave ablation


Other technologies

The market is segmented by the mode of treatment into-

Surgical ablation

Laparoscopic ablation

Percutaneous ablation

The market is segmented by the type of application into-

Liver cancer

Lung cancer

Kidney cancer

Bone metastasis

Other applications

The market is segmented by geography into North America, Europe, Asia-Pacific, and Rest of the World. Radiofrequency ablation holds a prominent share in its segment due to its high specificity and since it targets the tissue level without damaging the surrounding cells. Based on the mode of treatment, surgical ablation procedures have the largest share due to the increasing prevalence of liver and breast cancers, which require open surgical procedures. In the applications segment, liver cancer accounts for largest share due to the rising incidence of bile duct and primary liver cancer.

North America Ablation market share - By Technology (2016-2022)

Key Players

Some of the largest players in the tumor ablation market are:

Key Deliverables:

Market analysis for the tumor ablation market, with region-specific assessments and competition analysis.

Market definition along with the identification of key drivers, restraints, opportunities, and challenges.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.

Identification and analysis of the macro and micro factors that affect the global tumor ablation market.

Insights of the market in the regions that have the highest potential for growth and to also identify the markets that are still untapped.
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
1.7 Report Description
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Study Timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Model
2.4.4 Expert Validation
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Porter’s Five Force Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Degree of Competition
5.2.4 Threat of Substitution
5.2.5 Threat of New Entrants
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rise in Geriatric Population
6.1.2 Increasing Incidence of Cancer
6.1.3 Increase in Number of Hospitals, Ablation and Surgical Centers
6.1.4 Technological Advancement in Ablation Devices
6.1.5 Increase in Awareness for Personalized Drugs
6.1.6 Increase in Health Care Expenditure
6.2 Market Restraints
6.2.1 Strict Regulatory Process
6.3 Market Opportunities
6.3.1 Growing Government Support
6.3.2 Increasing Investment in R&D
6.4 Key Challenges
6.4.1 Long Approval Time for Product Launch
7. Global Tumor Ablation Market -Segmentation
7.1 Based on Type of Technology
7.1.1 Radiofrequency (Rf) Ablation
7.1.2 Microwave Ablation
7.1.3 Cryoablation
7.1.4 Other Technologies
7.2 Based on Mode of Treatment
7.2.1 Surgical Ablation
7.2.2 Laparoscopic Ablation
7.2.3 Percutaneous Ablation
7.3 Based on Type of Application
7.3.1 Liver Cancer
7.3.2 Lung Cancer
7.3.3 Kidney Cancer
7.3.4 Bone Metastasis
7.3.5 Other Applications
8. Global Tumor Ablation Market by Geography - Regional Share and Forecasts
8.1 North America
8.1.1 United States
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 UK
8.2.3 France
8.2.4 Italy
8.2.5 Spain & Portugal
8.2.6 Scandinavia
8.2.7 Benelux
8.2.8 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 India
8.3.4 Australia & New Zealand
8.3.5 South Korea
8.3.6 Rest of Asia-Pacific
8.4 Middle East and Africa
8.4.1 GCC
8.4.2 South Africa
8.4.3 Rest of Middle East and Africa
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Rest of Latin America
9. Competitive Landscape
9.1 Merger and Acquisition Analysis
9.2 New Product Launches
9.3 Agreements, Collaborations & Partnerships
10. Company Profiles
10.1 AngioDynamics Inc.
10.2 Galil Medical, Inc.
10.3 NeuWave Medical, Inc.
10.4 Medtronic PLC
10.5 INTIO Inc.
10.6 SonaCare Medical, LLC
10.7 Misonix, Inc.
10.8 BVM Medical Limited
10.9 COMSOL Inc.
10.10 Boston Scientific Corporation
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown